Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniel Pölöske
Observed name:
Pölöske, Daniel
Institutions:
University of Veterinary Medicine Vienna,
Medical University of Vienna
Observed institutions:
University of Vienna,
University of Veterinary Medicine Vienna,
Vienna General Hospital,
Medical University of Vienna
ORCID:
0009-0008-0515-1728
Observed ORCID:
0009-0008-0515-1728
OpenAlex ID:
A5055510016
AMPK leads to phosphorylation of the transcription factor Nrf2, tuning transactivation of selected target genes
2019
·
Manuel Matzinger
, Katrin Fischhuber
, et al.
·
Redox Biology
·
152
PDF
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma
2022
·
Helena Sorger
, Saptaswa Dey
, et al.
·
EMBO Molecular Medicine
·
26
Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability
2025
·
Harsimran K. Garcha
, Olasunkanmi O. Olaoye
, et al.
·
Journal of Medicinal Chemistry
·
24
Electrophilic MiniFrags Revealed Unprecedented Binding Sites for Covalent HDAC8 Inhibitors
2023
·
Aaron B. Keeley
, Aleksandra Kopranovic
, et al.
·
Journal of Medicinal Chemistry
·
17
PDF
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia
2024
·
Tobias Suske
, Helena Sorger
, et al.
·
Journal of Clinical Investigation
·
16
PDF
Dual specific STAT3/5 degraders effectively block acute myeloid leukemia and natural killer/T cell lymphoma
2024
·
Daniel Pölöske
, Helena Sorger
, et al.
·
HemaSphere
·
8
PDF
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma
2022
·
Harsimran Kaur Garcha
, Nabanita Nawar
, et al.
·
Pharmaceuticals
·
7
PDF
Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia
2021
·
Javier Bregante
, Anna Schönbichler
, et al.
·
Cancers
·
7
PDF
Multiomics Profiling of T-cell Leukemia and Lymphoma Enables Targeted Therapeutic Discovery
2025
·
Aleksandr Ianevski
, Kristen Nader
, et al.
·
Cancer Research
·
6
PDF
STAT5 Gain-of-Function Variants Promote Precursor T-Cell Receptor Activation to Drive T-Cell Acute Lymphoblastic Leukemia
2022
·
Tobias Suske
, Helena Sorger
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
2
PDF
[18F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinoma
2026
·
Stefan Stoiber
, Daniel Pölöske
, et al.
·
Molecular Cancer
Thyroid hormone receptor beta signaling is a targetable driver of prostate cancer growth
2025
·
Aleksandra Fesiuk
, Daniel Pölöske
, et al.
·
Molecular Cancer
PDF
Pharmacological Targeting of Oncogenic STAT3/5 Activity in Acute Myeloid Leukemia and Non-Hodgkin Lymphomas
2024
·
Pölöske, Daniel
·
Phaidra - Repository of the University of Veterinary Medicine, Vienna
Show more works
View as search
Works count:
16
Citation count:
265
H-index:
7
I10-index:
5
Year
Topic
Type